Financial results - IMAGISTICA MEDICALA DR. ANDREI PAVEL S.R.L.

Financial Summary - Imagistica Medicala Dr. Andrei Pavel S.r.l.
Unique identification code: 40593047
Registration number: J12/452/2019
Nace: 8690
Sales - Ron
82.867
Net Profit - Ron
55.274
Employee
1
The most important financial indicators for the company Imagistica Medicala Dr. Andrei Pavel S.r.l. - Unique Identification Number 40593047: sales in 2023 was 82.867 euro, registering a net profit of 55.274 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Alte activitati referitoare la sanatatea umana having the NACE code 8690.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Imagistica Medicala Dr. Andrei Pavel S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - - 13.964 44.137 62.213 70.437 82.867
Total Income - EUR - - - - - 13.964 44.137 62.213 70.437 82.867
Total Expenses - EUR - - - - - 682 2.437 8.978 25.267 26.888
Gross Profit/Loss - EUR - - - - - 13.282 41.701 53.235 45.171 55.979
Net Profit/Loss - EUR - - - - - 12.835 40.434 51.856 43.438 55.274
Employees - - - - - 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 18.0%, from 70.437 euro in the year 2022, to 82.867 euro in 2023. The Net Profit increased by 11.968 euro, from 43.438 euro in 2022, to 55.274 in the last year.

Check the financial reports for the company - Imagistica Medicala Dr. Andrei Pavel S.r.l.

Rating financiar

Financial Rating -
Imagistica Medicala Dr. Andrei...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Imagistica Medicala Dr. Andrei...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Imagistica Medicala Dr. Andrei...

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Imagistica Medicala Dr. Andrei...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Imagistica Medicala Dr. Andrei Pavel S.r.l. - CUI 40593047

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - - 2.669 1.692 59.608 49.915 36.849
Current Assets - - - - - 10.372 39.367 66.602 11.470 36.807
Inventories - - - - - 202 503 492 1.093 1.469
Receivables - - - - - 1.111 5.385 5.885 4.260 2.381
Cash - - - - - 9.059 33.478 60.226 6.116 32.956
Shareholders Funds - - - - - 12.877 40.483 91.442 43.222 55.323
Social Capital - - - - - 42 41 40 41 40
Debts - - - - - 164 575 58.337 41.805 42.489
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8690 - 8690"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 36.807 euro in 2023 which includes Inventories of 1.469 euro, Receivables of 2.381 euro and cash availability of 32.956 euro.
The company's Equity was valued at 55.323 euro, while total Liabilities amounted to 42.489 euro. Equity increased by 12.232 euro, from 43.222 euro in 2022, to 55.323 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Imagistica Medicala Dr. Andrei Pavel S.r.l.

Comments - Imagistica Medicala Dr. Andrei Pavel S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.